427 related articles for article (PubMed ID: 34282151)
41. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
42. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
[TBL] [Abstract][Full Text] [Related]
43. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis.
Beon M; Harley RA; Wessels A; Silver RM; Ludwicka-Bradley A
Clin Exp Rheumatol; 2004; 22(6):733-42. PubMed ID: 15638048
[TBL] [Abstract][Full Text] [Related]
44. Is Nox4 a key regulator of the activated state of fibroblasts in systemic sclerosis?
Böhm M; Dosoki H; Kerkhoff C
Exp Dermatol; 2014 Sep; 23(9):679-81. PubMed ID: 25040787
[TBL] [Abstract][Full Text] [Related]
45. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Jimenez SA; Piera-Velazquez S
Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
[TBL] [Abstract][Full Text] [Related]
46. β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.
Beyer C; Schramm A; Akhmetshina A; Dees C; Kireva T; Gelse K; Sonnylal S; de Crombrugghe B; Taketo MM; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 May; 71(5):761-7. PubMed ID: 22328737
[TBL] [Abstract][Full Text] [Related]
47. Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts.
Wasson CW; Ross RL; Wells R; Corinaldesi C; Georgiou IC; Riobo-Del Galdo NA; Del Galdo F
Arthritis Res Ther; 2020 Dec; 22(1):286. PubMed ID: 33303026
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling.
Yokoyama Y; Sekiguchi A; Fujiwara C; Uchiyama A; Uehara A; Ogino S; Torii R; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2018 Oct; 70(10):1661-1672. PubMed ID: 29676521
[TBL] [Abstract][Full Text] [Related]
50. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis.
Yasuoka H; Yamaguchi Y; Feghali-Bostwick CA
PLoS One; 2014; 9(2):e87754. PubMed ID: 24551065
[TBL] [Abstract][Full Text] [Related]
51. Interferon-γ Induces Interleukin-6 Production and Alpha-smooth Muscle Actin Expression in Systemic Sclerosis Fibroblasts.
Rokni M; Farhadi E; Kavosi H; Akhtari M; Madreseh E; Enayati S; Sadeghi Shaker M; Mostafaei S; Gharibdoost F; Mahmoudi M; Vodjgani M
Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):197-220. PubMed ID: 38822514
[TBL] [Abstract][Full Text] [Related]
52. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
53. Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts.
Yin Z; Carbone LD; Gotoh M; Postlethwaite A; Bolen AL; Tigyi GJ; Murakami-Murofushi K; Watsky MA
Rheumatology (Oxford); 2010 Dec; 49(12):2290-7. PubMed ID: 20823096
[TBL] [Abstract][Full Text] [Related]
54. Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma.
Werner G; Sanyal A; Mirizio E; Hutchins T; Tabib T; Lafyatis R; Jacobe H; Torok KS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372943
[TBL] [Abstract][Full Text] [Related]
55. Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis.
Rosa I; Romano E; Fioretto BS; El Aoufy K; Bellando-Randone S; Matucci-Cerinic M; Manetti M
Cells; 2023 Sep; 12(17):. PubMed ID: 37681927
[TBL] [Abstract][Full Text] [Related]
56. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
[TBL] [Abstract][Full Text] [Related]
57. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
Affandi AJ; Carvalheiro T; Ottria A; Broen JC; Bossini-Castillo L; Tieland RG; Bon LV; Chouri E; Rossato M; Mertens JS; Garcia S; Pandit A; de Kroon LM; Christmann RB; Martin J; van Roon JA; Radstake TR; Marut W
Ann Rheum Dis; 2019 Sep; 78(9):1249-1259. PubMed ID: 31126957
[TBL] [Abstract][Full Text] [Related]
58. Impaired Mitochondrial Transcription Factor A Expression Promotes Mitochondrial Damage to Drive Fibroblast Activation and Fibrosis in Systemic Sclerosis.
Zhou X; Trinh-Minh T; Tran-Manh C; Gießl A; Bergmann C; Györfi AH; Schett G; Distler JHW
Arthritis Rheumatol; 2022 May; 74(5):871-881. PubMed ID: 34807516
[TBL] [Abstract][Full Text] [Related]
59. c-Abl silencing reduced the inhibitory effects of TGF-β1 on apoptosis in systemic sclerosis dermal fibroblasts.
Karimizadeh E; Gharibdoost F; Motamed N; Jafarinejad-Farsangi S; Jamshidi A; Mahmoudi M
Mol Cell Biochem; 2015 Jul; 405(1-2):169-76. PubMed ID: 25876876
[TBL] [Abstract][Full Text] [Related]
60. Fibroblast Activation Protein Targeted Photodynamic Therapy Selectively Kills Activated Skin Fibroblasts from Systemic Sclerosis Patients and Prevents Tissue Contraction.
Dorst DN; van Caam APM; Vitters EL; Walgreen B; Helsen MMA; Klein C; Gudi S; Wubs T; Kumari J; Vonk MC; van der Kraan PM; Koenders MI
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
